Oncology News | pharmaphorum

News

Gilead drops CD47 drug magrolimab for blood cancers

Gilead Sciences has said it will no longer develop its CD47-targeting antibody magrolimab in blood cancers after data suggested that patients taking the drug in clinical t

News

NHS England pushes BRCA testing for Jewish community

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer.

News

Jazz buys KRAS inhibitors from Redx in $880m deal

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma,

News

GSK backs up its Blenrep rehab bid with survival data

GSK has revealed the data it hopes will allow a return to the US market for Blenrep, which was the first BCMA-targeting drug to launch there, but was withdrawn from sale after it fail

News

Pfizer partners American Cancer Society on health equity

A new $15 million initiative between Pfizer and the American Cancer Society (ACS) aims to tackle one of the most pressing issues in health at the moment – unequal access t

News

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

Novartis is continuing a streak of pipeline-building deals with an agreement to buy Germany’s MorphoSys in a transaction that values the cancer-focused biotech at €2.7 billion (around

Gilead drops CD47 drug magrolimab for blood cancers

NHS England pushes BRCA testing for Jewish community

Jazz buys KRAS inhibitors from Redx in $880m deal

GSK backs up its Blenrep rehab bid with survival data

Pfizer partners American Cancer Society on health equity

More pharma M&A as Novartis snaps up MorphoSys for $2.9bn

CMS aims for broader GLP-1 access via federal programmes

How to meet your physicians where they are online

News

Editor's Picks